Detalhe da pesquisa
1.
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
AIDS Behav
; 27(9): 3027-3037, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929319
2.
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features.
PLoS Comput Biol
; 15(4): e1006952, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30933973
3.
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
Lancet
; 388(10040): 158-69, 2016 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27212429
4.
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.
Sci Transl Med
; 15(697): eadf3309, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224227
5.
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
Nat Med
; 24(9): 1430-1440, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082858
6.
Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America.
Vaccine
; 35(28): 3591-3597, 2017 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28455172
7.
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
Lancet Infect Dis
; 15(11): 1273-82, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26318714
8.
Comparison of threshold selection methods for microarray gene co-expression matrices.
BMC Res Notes
; 2: 240, 2009 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19954523